Rockefeller Capital Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,864
| Closed | -$2K | – | 2381 |
|
|
2022
Q4 | $2K | Sell |
1,864
-485
| -21% | -$520 | ﹤0.01% | 3551 |
|
|
2022
Q3 | $3K | Hold |
2,349
| – | – | ﹤0.01% | 3468 |
|
|
2022
Q2 | $4K | Hold |
2,349
| – | – | ﹤0.01% | 3520 |
|
|
2022
Q1 | $6K | Hold |
2,349
| – | – | ﹤0.01% | 3265 |
|
|
2021
Q4 | $10K | Hold |
2,349
| – | – | ﹤0.01% | 2971 |
|
|
2021
Q3 | $11K | Hold |
2,349
| – | – | ﹤0.01% | 2839 |
|
|
2021
Q2 | $14K | Hold |
2,349
| – | – | ﹤0.01% | 2631 |
|
|
2021
Q1 | $18K | Hold |
2,349
| – | – | ﹤0.01% | 2322 |
|
|
2020
Q4 | $15K | Hold |
2,349
| – | – | ﹤0.01% | 2108 |
|
|
2020
Q3 | $15K | Buy |
+2,349
| New | +$15K | ﹤0.01% | 1879 |
|